120 related articles for article (PubMed ID: 6226856)
41. Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
Cornell CJ; Hoth D; Pajak TF
Cancer Treat Rep; 1981; 65(7-8):734-5. PubMed ID: 6454488
[No Abstract] [Full Text] [Related]
42. Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.
Bukowski RM; Tangen C; Lee R; Macdonald JS; Einstein AB; Peterson R; Fleming TR
J Clin Oncol; 1992 Dec; 10(12):1914-8. PubMed ID: 1333517
[TBL] [Abstract][Full Text] [Related]
43. [Phase II study of 3 new nitrosoureas, 1 American (chlorozotocin) and 2 French (RFCNU and RPCNU)].
Mathé G; Schein PS; De Vassal F; Serrou B; Imbach JL
Sem Hop; 1982 Sep; 58(33):1867-71. PubMed ID: 6293062
[TBL] [Abstract][Full Text] [Related]
44. Nitrosourea chemotherapeutic agents: Chlorozotocin.
National Toxicology Program
Rep Carcinog; 2011; 12():328-9. PubMed ID: 21860521
[No Abstract] [Full Text] [Related]
45. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
46. A phase I study of chlorozotocin (NSC 178248).
Kovach JS; Moertel CG; Schutt AJ; Frytak S; O'Connell MJ; Rubin J; Ingle JN
Cancer; 1979 Jun; 43(6):2189-96. PubMed ID: 156580
[TBL] [Abstract][Full Text] [Related]
47. ECOG phase II trials of MGBG, chlorozotocin, COM multidrug therapy in advanced measurable colorectal cancer.
Douglass HO; Lefkopoulou M; Davis HL; Taylor SG; Falkson G; Mittelman A; MacIntyre J; Engstrom PF
Am J Clin Oncol; 1988 Dec; 11(6):646-9. PubMed ID: 2973226
[TBL] [Abstract][Full Text] [Related]
48. Combination chemotherapy pneumonitis: a case report of possible synergistic toxicity.
Goedert JJ; Smith FP; Tsou E; Weiss RB
Med Pediatr Oncol; 1983; 11(2):116-8. PubMed ID: 6220198
[TBL] [Abstract][Full Text] [Related]
49. Chlorozotocin.
Rep Carcinog; 2004; 11():III62-3. PubMed ID: 21089833
[No Abstract] [Full Text] [Related]
50. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
[TBL] [Abstract][Full Text] [Related]
51. Contributions of nitrosoureas to cancer treatment.
Mitchell EP; Schein PS
Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
[No Abstract] [Full Text] [Related]
52. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
53. [Clinical evaluation of effects and improvement in quality of life from palliative therapy of combination chemotherapy with Furtulon and consecutive low-dose cisplatin in cases of unresectable advanced gastrointestinal carcinoma].
Tong F; Liu H; Wang S; Yang D; Gu J; Qiao X; Zhang J
Gan To Kagaku Ryoho; 2001 Feb; 28(2):205-9. PubMed ID: 11242647
[TBL] [Abstract][Full Text] [Related]
54. Combination chemotherapy in advanced gastrointestinal malignancy.
Vaughn CB; Brady P; Chinn BJ; Daversa GC; Parzuchowski JS
Oncology; 1980; 37(1):57-61. PubMed ID: 6985729
[TBL] [Abstract][Full Text] [Related]
55. Clinical trials for advanced gastrointestinal cancers in Japan. Japan Clinical Oncology Group Gastrointestinal Oncology Study Group.
Shimada Y
Cancer Chemother Pharmacol; 1998; 42 Suppl():S80-4. PubMed ID: 9750035
[TBL] [Abstract][Full Text] [Related]
56. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
57. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Becouarn Y; Brunet R; Bussières E; Marée D
Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
[TBL] [Abstract][Full Text] [Related]
58. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
59. Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies.
Valone FH; Gandara DR; Luce JA; Wall S; Perez EA; Braham N; George M; Letvak L
Cancer Chemother Pharmacol; 1993; 32(3):215-20. PubMed ID: 8500227
[TBL] [Abstract][Full Text] [Related]
60. [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
Koda K; Nakazawa O; Morita K; Kure T; Terada S; Matsunaga T; Tsuji Y; Miyazaki E; Nakajima K; Morii K
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1893-900. PubMed ID: 2118336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
